Posted April 22, 2012 Rosiglitazone, branded under Avandia and marketed as a drug to help diabetics process insulin by manufacturer GlaxoSmithKline, has been the focus of several lawsuits in the United States and Europe. Due to the reported side effects, Avandia declined in popularity and is now subject to restrictions placed by the Food and Full Article…
Search LawsuitInformation.org
Federal Court Begins the Selection Process for Initial Avandia Suits
Posted March 29, 2012 by Digital Journal A federal district court judge recently indicated that her court is preparing to schedule for trial almost one hundred cases involving the diabetes drug Avandia. March 29, 2012 /24-7PressRelease/ – A federal district court judge recently indicated that her court is preparing to schedule for trial almost one Full Article…
GSK Settles More than 25,000 Avandia Cases on Heart Attacks
Posted March 2, 2012 by PR Web On February 18th, 2012 Bloomberg reported that more than 25,000 cases were settled by GlaxoSmithKline Plc (GSK), the United Kingdom’s largest pharmaceutical company, over its Avandia drug allegedly causing heart attacks. Avandia was first approved by the FDA in 1999 to treat Type 2 diabetes in adult patients. Full Article…
GSK Boss Gets $1.2Million Pay Cut After Poor Year
Posted March 2, 2011 on LSE LONDON, March 2 (Reuters) – GlaxoSmithKline Chief Executive Andrew Witty’s pay was cut by 734, 000 pounds ($1.2 million) to 2.3 million pounds last year after Britain’s biggest drugmaker missed its profit targets. The shortfall followed plunging sales of controversial diabetes pill Avandia, which was withdrawn from the market Full Article…
Drugs, water retention tied to heart risks
Posted February 26, 2011 on UPI.com CLEVELAND, Feb. 26 (UPI) – Fluid retention may explain why medications such as Vioxx, Bextra and Avandia can increase the risk of heart attacks and strokes, U.S. researchers suggest. Dr. Robert P. Blankfield of Case Western Reserve University School of Medicine in Cleveland used several basic cardiovascular and hydraulic Full Article…
GSK Revises U.S. Avandia Label to Include New Restrictions
Posted February 17, 2011 by PharmPro GlaxoSmithKline (GSK) today announced revised US prescribing information and medication guides for all rosiglitazone-containing medicines (Avandia®, Avandamet® and Avandaryl®) to include additional safety information and restrictions on the use of these medicines. The new label content reflects the US Food and Drug Administration’s review of cardiovascular event data in Full Article…
Interested to Know About Avandia Lawsuits? Look HERE
Posted February 19, 2011 by vala123 When the studies proved the risks of taking Avandia and was published in the website of New English Journal of Medicine in 2007, the public became alarmed and the Avandia users started filing lawsuits against the manufacturer. GlaxoSmithKline, Avandia’s manufacturer, received an order from the Food and Drug Administration Full Article…
Avandia to be withdrawn in April – New Zealand
Posted February 16, 2011 on Amanda Cameron Controversial diabetes drug Avandia will be withdrawn from the New Zealand market on 29 April because it raises the risk of having a heart attack. Medsafe has just announced it is making the move after a safety review confirmed the suspected cardiovascular risks of the medicine, meaning its Full Article…
FDA Updates Info Guide on Avandia Side Effects
Posted February 10, 2011 on Seedol U.S. Food and Drug Administration (FDA) announced Thursday that updated information of Avandia side effects has been added to physician labeling and patient Medication Guide. The FDA, a federal agency of the United States, is responsible for protecting and promoting public health through the regulation and supervision of food Full Article…
Avandia Lawsuit Settled by GlaxoSmithKline Day Before Scheduled Trial
Posted February 1, 2011 on DrugWatch On January 31, British drug manufacturer GlaxoSmithKline settled a U.S. federal court case involving popular diabetes drug Avandia the day before it was scheduled to go to trial. The lawsuit claimed the medication led to a North Carolina man’s death after he suffered a heart attack following use of Full Article…
